Validation of plasma branched chain amino acids as biomarkers in Huntington Disease

Archives of Neurology

Volumn 68, Issue 2, 2011, Pages 265-267

  Mochel, Fanny ^a,b   Benaich, Sandra ^b   Rabier, Daniel ^c   Durr, Alexandra ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE; VALINE;

BODY MASS; CATABOLISM; DISEASE SEVERITY; HUNTINGTON CHOREA; INBORN ERROR OF METABOLISM; LETTER; MULTIVARIATE ANALYSIS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RATING SCALE;

ADULT; AGED; AMINO ACIDS, BRANCHED-CHAIN; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; HUNTINGTON DISEASE; ISOLEUCINE; LEUCINE; LINEAR MODELS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT EXPANSION; VALINE;

EID: 79951546457     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.358     Document Type: Letter

References (5)

1. Mochel F, Charles P, Seguin F, et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One. 2007;2(7):e647.
2. Flier JS. Neuroscience: regulating energy balance: the substrate strikes back. Science. 2006;312(5775):861-864. (Pubitemid 43727307)
3. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18(16):1926-1945. (Pubitemid 39071573)
4. Colin E, Régulier E, Perrin V, et al. Akt is altered in an animal model of Huntington's disease and in patients. Eur J Neurosci. 2005;21(6):1478-1488. (Pubitemid 40646594)
5. Heng MY, Duong DK, Albin RL, et al. Early autophagic response in a novel knock-in model of Huntington disease. Hum Mol Genet. 2010;19(19):3702-3720.